Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01708460 · ClinicalTrials.gov registry record · NA

Feasibility Study: Ulthera Treatment of the Buttocks and Thighs

A NA study of Skin Laxity, sponsored by Ulthera.

Completed
Registry status
NA
Development phase
31
Enrollment target
1
Study location

NCT01708460 is a NA study of Skin Laxity that has completed, run by Ulthera. The registered enrollment target is 31 participants, below the 188-participant average among 10 other Skin Laxity trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01708460, a NA study of Skin Laxity, has completed, sponsored by Ulthera.

COMPLETED
Registry status
NA
Development phase
31 participants
Enrollment target
1
Study location

Study Summary

Up to 30 subjects will be enrolled. Enrolled subjects will receive an Ulthera® treatment to one side of the body, treating the lateral buttock region. Follow-up visits will occur at 90 and 180 days post-treatment. Study images will be obtained pre-treatment, immediately post-treatment, and at each follow-up visit.

Conditions Studied

Interventions

  • DEVICE Ulthera System Treatment

Study Locations (1)

New York

  • Skin Laser and Surgery Specialist of New York and New Jersey - New York

Trial Details

FieldValue
Enrollment Target 31 participants
Start Date 2011-12
Est. Completion 2013-07
Phase NA

Sponsor

Ulthera

42 total trials

What the Registry Record Tells You About NCT01708460

The ClinicalTrials.gov registry entry for NCT01708460 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 31 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 188-participant average among 10 other Skin Laxity trials with a reported enrollment target (84% lower). The listed sponsor is Ulthera, which has 42 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Skin Laxity appearing as the primary indexed condition, and to 1 intervention - of which Ulthera System Treatment is the first listed.

NCT01708460 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.

Frequently Asked Questions

What is clinical trial NCT01708460 about?

NCT01708460 is a clinical study titled "Feasibility Study: Ulthera Treatment of the Buttocks and Thighs". Up to 30 subjects will be enrolled. Enrolled subjects will receive an Ulthera® treatment to one side of the body, treating the lateral buttock region. Follow-up visits will occur at 90 and 180 days post-treatment. Study images will be obtained pre-treatment, immediately post-treatment, and at each f...

What is the current status of trial NCT01708460?

This trial is currently completed. It is a NA study. The enrollment target is 31 participants. The study started on 2011-12. Estimated completion is 2013-07.

What conditions does trial NCT01708460 study?

This clinical trial studies the following conditions: Skin Laxity.

What interventions are being tested in trial NCT01708460?

The interventions under investigation include: Ulthera System Treatment (DEVICE).

Who is sponsoring clinical trial NCT01708460?

This trial is sponsored by Ulthera, which has 42 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01708460 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Skin Laxity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.